Agios Pharmaceuticals Inc [AGIO] stock prices are down -0.66% to $37.7 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The AGIO shares have gain 2.50% over the last week, with a monthly amount glided 2.39%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Agios Pharmaceuticals Inc [NASDAQ: AGIO] stock has seen the most recent analyst activity on February 24, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $58. Leerink Partners downgraded its rating to a Market Perform and decreased its price target to $56 on September 27, 2024. Cantor Fitzgerald initiated its recommendation with a Overweight. Piper Sandler started tracking with a Overweight rating for this stock on February 03, 2023, and assigned it a price target of $41. In a note dated November 17, 2022, Goldman upgraded a Neutral rating on this stock and boosted its target price from $17 to $32.
The stock price of Agios Pharmaceuticals Inc [AGIO] has been fluctuating between $23.42 and $62.58 over the past year. Currently, Wall Street analysts expect the stock to reach $71 within the next 12 months. Agios Pharmaceuticals Inc [NASDAQ: AGIO] shares were valued at $37.7 at the most recent close of the market. An investor can expect a potential return of 88.33% based on the average AGIO price forecast.
Analyzing the AGIO fundamentals
The Agios Pharmaceuticals Inc [NASDAQ:AGIO] reported sales of 40.88M for trailing twelve months, representing a surge of 44.57%. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at -11.29%, Pretax Profit Margin comes in at 16.99%, and Net Profit Margin reading is 15.9%. To continue investigating profitability, this company’s Return on Assets is posted at 0.44, Equity is 0.43 and Total Capital is -0.33. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Agios Pharmaceuticals Inc [NASDAQ:AGIO]’s Current Ratio is 14.48. On the other hand, the Quick Ratio is 14.04, and the Cash Ratio is 1.15. Considering the valuation of this stock, the price to sales ratio is 53.58, the price to book ratio is 1.60 and price to earnings (TTM) ratio is 3.41.
Transactions by insiders
Recent insider trading involved Washburn Theodore James Jr., Principal Accounting Officer, that happened on Sep 05 ’25 when 8546.0 shares were sold. Director, Scadden David completed a deal on Aug 27 ’25 to sell 200.0 shares. Meanwhile, Director DAVID T. SCADDEN bought 200.0 shares on Aug 27 ’25.
